Changes in spirometry during consecutive admissions for infective pulmonary exacerbations in adolescent and adult cystic fibrosis
Related Experiment Video
Updated: Aug 18, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
1Department of Cystic Fibrosis, Brompton Hospital, London, U.K.
Insights
Cystic fibrosis (CF) patients experience declining lung function (FEV1, FVC) over time. Repeated hospitalizations for CF exacerbations show diminishing returns in lung function improvement with each admission.
Area of Science:
- Pulmonology
- Medical Research
Background:
- Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, primarily the lungs.
- Pulmonary infective exacerbations are a major cause of morbidity and mortality in CF patients.
- Repeated hospitalizations are common for managing CF exacerbations.
Purpose of the Study:
- To analyze changes in spirometry parameters during consecutive admissions for pulmonary infective exacerbations in CF patients.
- To assess the long-term impact of repeated exacerbation treatments on lung function.
- To evaluate lung function trends in severe cases requiring transplantation or leading to death.
Main Methods:
- Retrospective analysis of spirometry data (FEV1, FVC) from 45 CF patients.
- Inclusion criteria: five or more admissions for pulmonary infective exacerbations.
- Comparison of lung function changes over the study period and across consecutive admissions.
Main Results:
- Significant annual decline in FEV1 (-112.1 ml/yr) and FVC (-47.9 ml/yr) observed.
- Lung function (FEV1, FVC) improved during each admission but with diminishing magnitude over consecutive admissions.
- Patients who died or underwent transplantation had FEV1 below 800 ml at their last admission, despite treatment.
Conclusions:
- Consecutive admissions for CF exacerbations are associated with a progressive decline in lung function.
- The effectiveness of treatment in improving lung function diminishes with repeated exacerbations.
- Low FEV1 levels at last admission in severe cases indicate poor prognosis despite intensive care.
Abstract:
Changes in spirometry during consecutive admissions for treatment of pulmonary infective exacerbations were studied in 45 patients (24 males, 21 females) with cystic fibrosis (CF) who had required five or more such admissions. Over the overall study period there was a mean (SD) decline in FEV1 of -112.1 (188.0) ml yr-1 (P less than 0.001) and in FVC of -47.9 (82.4) ml yr-1 (P less than 0.001). FEV1 and FVC increased during each admission with treatment; however, the magnitude of this change became less over consecutive admissions by a mean value of -33.3 ml (45.0) (P less than 0.001) for FEV1, and -26.0 (72.2) ml (P less than 0.05) for FVC. In the majority of patients that died or underwent transplantation, FEV1 at the time of the last admission did not rise above 800 ml despite full treatment.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration can...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

